25 XP   0   0   10

BioRestorative Therapies Inc
Buy, Hold or Sell?

Let's analyse Biorestorative together

PenkeI guess you are interested in BioRestorative Therapies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioRestorative Therapies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BioRestorative Therapies Inc

I send you an email if I find something interesting about BioRestorative Therapies Inc.

Quick analysis of Biorestorative (30 sec.)










What can you expect buying and holding a share of Biorestorative? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.71
Expected worth in 1 year
$1.32
How sure are you?
35.9%

+ What do you gain per year?

Total Gains per Share
$-0.38
Return On Investment
-27.7%

For what price can you sell your share?

Current Price per Share
$1.38
Expected price per share
$1.2 - $1.54
How sure are you?
50%

1. Valuation of Biorestorative (5 min.)




Live pricePrice per Share (EOD)

$1.38

Intrinsic Value Per Share

$-9.17 - $-5.72

Total Value Per Share

$-7.46 - $-4.01

2. Growth of Biorestorative (5 min.)




Is Biorestorative growing?

Current yearPrevious yearGrowGrow %
How rich?$11.5m$16.2m-$3.9m-32.4%

How much money is Biorestorative making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$4.7m$2.7m140.1%
Net Profit Margin-6,510.3%-36,018.1%--

How much money comes from the company's main activities?

3. Financial Health of Biorestorative (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#661 / 1011

Most Revenue
#662 / 1011

Most Profit
#293 / 1011

Most Efficient
#922 / 1011

What can you expect buying and holding a share of Biorestorative? (5 min.)

Welcome investor! Biorestorative's management wants to use your money to grow the business. In return you get a share of Biorestorative.

What can you expect buying and holding a share of Biorestorative?

First you should know what it really means to hold a share of Biorestorative. And how you can make/lose money.

Speculation

The Price per Share of Biorestorative is $1.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biorestorative.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biorestorative, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.71. Based on the TTM, the Book Value Change Per Share is $-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biorestorative.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.42-30.2%-0.29-21.0%-0.62-44.6%-0.69-49.9%-0.51-37.0%
Usd Book Value Change Per Share-0.19-13.7%-0.10-6.9%-0.25-17.8%0.1510.8%0.075.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.19-13.7%-0.10-6.9%-0.25-17.8%0.1510.8%0.075.0%
Usd Price Per Share1.38-2.53-3.08-1.58-2.03-
Price to Earnings Ratio-0.83--13.23--1.31--2.88--2.36-
Price-to-Total Gains Ratio-7.31--2.06--13.06--6.40-1,264.17-
Price to Book Ratio0.81-1.39-1.31-0.55--1.46-
Price-to-Total Gains Ratio-7.31--2.06--13.06--6.40-1,264.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.38
Number of shares724
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.100.15
Usd Total Gains Per Share-0.100.15
Gains per Quarter (724 shares)-69.11108.08
Gains per Year (724 shares)-276.44432.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-276-2860432422
20-553-5620865854
30-829-838012971286
40-1106-1114017291718
50-1382-1390021622150
60-1659-1666025942582
70-1935-1942030263014
80-2212-2218034583446
90-2488-2494038913878
100-2764-2770043234310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%1.018.00.05.3%1.038.00.02.6%1.049.06.01.8%
Book Value Change Per Share1.02.00.033.3%3.08.00.027.3%6.013.00.031.6%14.025.00.035.9%17.039.00.030.4%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.039.00.0%1.00.055.01.8%
Total Gains per Share1.02.00.033.3%3.08.00.027.3%6.013.00.031.6%14.025.00.035.9%17.039.00.030.4%

Fundamentals of Biorestorative

About BioRestorative Therapies Inc

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.

Fundamental data was last updated by Penke on 2024-04-15 18:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BioRestorative Therapies Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biorestorative earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • A Net Profit Margin of -14,638.4% means that $-146.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioRestorative Therapies Inc:

  • The MRQ is -14,638.4%. The company is making a huge loss. -2
  • The TTM is -6,510.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14,638.4%TTM-6,510.3%-8,128.1%
TTM-6,510.3%YOY-36,018.1%+29,507.8%
TTM-6,510.3%5Y-37,917.0%+31,406.8%
5Y-37,917.0%10Y-24,699.0%-13,218.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14,638.4%-196.1%-14,442.3%
TTM-6,510.3%-211.9%-6,298.4%
YOY-36,018.1%-277.7%-35,740.4%
5Y-37,917.0%-432.9%-37,484.1%
10Y-24,699.0%-599.3%-24,099.7%
1.1.2. Return on Assets

Shows how efficient Biorestorative is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • -22.4% Return on Assets means that Biorestorative generated $-0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioRestorative Therapies Inc:

  • The MRQ is -22.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.4%TTM-15.1%-7.3%
TTM-15.1%YOY-28.4%+13.3%
TTM-15.1%5Y-83.4%+68.2%
5Y-83.4%10Y-115.9%+32.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.4%-13.3%-9.1%
TTM-15.1%-12.7%-2.4%
YOY-28.4%-11.8%-16.6%
5Y-83.4%-14.0%-69.4%
10Y-115.9%-15.9%-100.0%
1.1.3. Return on Equity

Shows how efficient Biorestorative is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • -24.5% Return on Equity means Biorestorative generated $-0.24 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioRestorative Therapies Inc:

  • The MRQ is -24.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.5%TTM-16.4%-8.1%
TTM-16.4%YOY-29.7%+13.3%
TTM-16.4%5Y-15.0%-1.4%
5Y-15.0%10Y-7.3%-7.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.5%-16.9%-7.6%
TTM-16.4%-16.0%-0.4%
YOY-29.7%-15.1%-14.6%
5Y-15.0%-19.7%+4.7%
10Y-7.3%-20.5%+13.2%

1.2. Operating Efficiency of BioRestorative Therapies Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biorestorative is operating .

  • Measures how much profit Biorestorative makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • An Operating Margin of -16,687.5% means the company generated $-166.87  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioRestorative Therapies Inc:

  • The MRQ is -16,687.5%. The company is operating very inefficient. -2
  • The TTM is -10,589.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16,687.5%TTM-10,589.6%-6,097.9%
TTM-10,589.6%YOY-41,851.8%+31,262.2%
TTM-10,589.6%5Y-38,011.5%+27,421.9%
5Y-38,011.5%10Y-23,902.6%-14,109.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16,687.5%-290.9%-16,396.6%
TTM-10,589.6%-224.4%-10,365.2%
YOY-41,851.8%-288.3%-41,563.5%
5Y-38,011.5%-479.5%-37,532.0%
10Y-23,902.6%-625.2%-23,277.4%
1.2.2. Operating Ratio

Measures how efficient Biorestorative is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 167.87 means that the operating costs are $167.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 167.875. The company is inefficient in keeping operating costs low. -1
  • The TTM is 107.261. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ167.875TTM107.261+60.614
TTM107.261YOY421.540-314.280
TTM107.2615Y221.409-114.149
5Y221.40910Y188.182+33.227
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ167.8753.110+164.765
TTM107.2613.266+103.995
YOY421.5403.783+417.757
5Y221.4095.657+215.752
10Y188.1827.783+180.399

1.3. Liquidity of BioRestorative Therapies Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biorestorative is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.71 means the company has $10.71 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 10.712. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.014. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.712TTM13.014-2.303
TTM13.014YOY28.638-15.624
TTM13.0145Y13.508-0.494
5Y13.50810Y6.599+6.909
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.7123.905+6.807
TTM13.0144.212+8.802
YOY28.6385.337+23.301
5Y13.5086.062+7.446
10Y6.5996.401+0.198
1.3.2. Quick Ratio

Measures if Biorestorative is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • A Quick Ratio of 20.00 means the company can pay off $20.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 19.999. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 23.363. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ19.999TTM23.363-3.364
TTM23.363YOY44.427-21.064
TTM23.3635Y18.337+5.026
5Y18.33710Y8.946+9.391
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.9993.572+16.427
TTM23.3634.001+19.362
YOY44.4275.364+39.063
5Y18.3376.009+12.328
10Y8.9466.287+2.659

1.4. Solvency of BioRestorative Therapies Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biorestorative assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biorestorative to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Biorestorative assets are financed with 8.4% credit (debt) and the remaining percentage (100% - 8.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 0.084. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.074. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.084TTM0.074+0.010
TTM0.074YOY0.043+0.031
TTM0.0745Y4.466-4.392
5Y4.46610Y4.735-0.269
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0840.336-0.252
TTM0.0740.334-0.260
YOY0.0430.271-0.228
5Y4.4660.366+4.100
10Y4.7350.389+4.346
1.4.2. Debt to Equity Ratio

Measures if Biorestorative is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • A Debt to Equity ratio of 9.2% means that company has $0.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 0.092. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.080. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.092TTM0.080+0.012
TTM0.080YOY0.046+0.035
TTM0.0805Y0.026+0.054
5Y0.02610Y0.013+0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0920.382-0.290
TTM0.0800.397-0.317
YOY0.0460.341-0.295
5Y0.0260.432-0.406
10Y0.0130.465-0.452

2. Market Valuation of BioRestorative Therapies Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biorestorative generates.

  • Above 15 is considered overpriced but always compare Biorestorative to the Biotechnology industry mean.
  • A PE ratio of -0.83 means the investor is paying $-0.83 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioRestorative Therapies Inc:

  • The EOD is -0.827. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.827. Based on the earnings, the company is expensive. -2
  • The TTM is -13.229. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.827MRQ-0.8270.000
MRQ-0.827TTM-13.229+12.402
TTM-13.229YOY-1.311-11.918
TTM-13.2295Y-2.879-10.349
5Y-2.87910Y-2.356-0.524
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.827-2.262+1.435
MRQ-0.827-2.599+1.772
TTM-13.229-2.674-10.555
YOY-1.311-4.133+2.822
5Y-2.879-6.258+3.379
10Y-2.356-6.171+3.815
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioRestorative Therapies Inc:

  • The EOD is -1.267. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.267. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.417. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.267MRQ-1.2670.000
MRQ-1.267TTM-3.417+2.150
TTM-3.417YOY-3.103-0.314
TTM-3.4175Y-2.468-0.949
5Y-2.46810Y-3.266+0.797
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.267-2.913+1.646
MRQ-1.267-3.275+2.008
TTM-3.417-3.508+0.091
YOY-3.103-5.620+2.517
5Y-2.468-8.306+5.838
10Y-3.266-8.854+5.588
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biorestorative is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.81 means the investor is paying $0.81 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioRestorative Therapies Inc:

  • The EOD is 0.809. Based on the equity, the company is cheap. +2
  • The MRQ is 0.809. Based on the equity, the company is cheap. +2
  • The TTM is 1.387. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.809MRQ0.8090.000
MRQ0.809TTM1.387-0.578
TTM1.387YOY1.311+0.076
TTM1.3875Y0.549+0.838
5Y0.54910Y-1.464+2.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8091.858-1.049
MRQ0.8092.090-1.281
TTM1.3872.091-0.704
YOY1.3112.866-1.555
5Y0.5493.488-2.939
10Y-1.4643.836-5.300
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of BioRestorative Therapies Inc.

3.1. Institutions holding BioRestorative Therapies Inc

Institutions are holding 9.602% of the shares of BioRestorative Therapies Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc1.83980120633-17185-12.4693
2023-12-31Geode Capital Management, LLC0.6604327800
2023-12-31Wealth Alliance, LLC0.610.00984000000
2023-12-31Mariner Wealth Advisors, LLC0.40920.0001268311630.6112
2023-12-31State Street Corporation0.31202045900
2023-12-31Two Sigma Advisers, LLC0.30040.000119700-4900-19.9187
2023-12-31HRT FINANCIAL LLC0.19040.000212485124850
2023-12-31Advisor Group Holdings, Inc.0.03350219400
2023-12-31Wells Fargo & Co0.029801951-7394-79.1225
2023-12-31Tower Research Capital LLC0.012908448440
2023-12-31UBS Group AG0.0014094939300
2023-12-31Bank of America Corp0.0008054540
2023-12-31Parallel Advisors, LLC00100
2023-12-31Cornerstone Planning Group LLC00100
2023-09-30Householder Group Estate & Retirement Specialist, LLC000-200-100
2023-09-30Steward Partners Investment Advisory, LLC000-2000-100
2023-09-30Jjj Advisors Inc000-1-100
2023-12-31FNY Investment Advisers, LLC000-14665-100
2023-12-31StoneX Group Inc000-23880-100
2023-12-31JPMorgan Chase & Co000-4-100
Total 4.40020.0102288525-56590-19.6%

3.2. Funds holding BioRestorative Therapies Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Extended Market Index0.3040.000120582-100-0.4835
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.302402047200
2024-02-29Fidelity Total Market Index0.240901630600
2024-02-29Fidelity Nasdaq Composite Index0.0570386200
2024-03-31NT Ext Equity Mkt Idx Fd - L0.03590.0001243100
2023-12-31Northern Trust Extended Eq Market Idx0.03590.0001243100
2024-02-29Fidelity Series Total Market Index0.02050138500
2024-02-29Spartan Total Market Index Pool E0.01540104300
2023-09-30Blackstone Alternative Multi-Strategy I0.0059040000
2024-02-29Spartan Extended Market Index Pool E0.001501001000
Total 1.01940.00036901200.0%

3.3. Insider Transactions

Insiders are holding 18.8% of the shares of BioRestorative Therapies Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-08Francisco SilvaBUY17081.16
2024-02-09Dale BroadrickBUY860411.32
2024-02-07Dale BroadrickBUY363741.38
2023-12-01Dale BroadrickSELL2501.88
2023-11-27Dale BroadrickSELL2781.89
2023-09-15Lance AlstodtBUY22001.7
2023-09-14Dale BroadrickBUY100001.54
2023-09-13Lance AlstodtBUY8001.53
2023-09-07Dale BroadrickBUY10001.81
2023-09-06Lance AlstodtBUY28871.96
2023-08-31Francisco SilvaBUY49542.22
2023-07-28Dale BroadrickBUY5002.89

4. Summary

4.1. Key Performance Indicators

The key performance indicators of BioRestorative Therapies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.189-0.095-49%-0.246+30%0.149-226%0.069-373%
Book Value Per Share--1.7061.811-6%2.397-29%0.660+159%-0.138+108%
Current Ratio--10.71213.014-18%28.638-63%13.508-21%6.599+62%
Debt To Asset Ratio--0.0840.074+14%0.043+94%4.466-98%4.735-98%
Debt To Equity Ratio--0.0920.080+15%0.046+102%0.026+250%0.013+618%
Dividend Per Share----0%-0%-0%-0%
Eps---0.417-0.290-31%-0.615+47%-0.689+65%-0.511+22%
Free Cash Flow Per Share---0.272-0.206-24%-0.259-5%-0.163-40%-0.165-39%
Free Cash Flow To Equity Per Share---0.260-0.091-65%-0.213-18%0.398-165%0.208-225%
Gross Profit Margin--1.0001.0000%1.0000%1.0040%1.011-1%
Intrinsic Value_10Y_max---5.716--------
Intrinsic Value_10Y_min---9.165--------
Intrinsic Value_1Y_max---0.648--------
Intrinsic Value_1Y_min---0.849--------
Intrinsic Value_3Y_max---1.889--------
Intrinsic Value_3Y_min---2.627--------
Intrinsic Value_5Y_max---3.062--------
Intrinsic Value_5Y_min---4.473--------
Market Cap9342489.6000%9342489.60017105331.200-45%20868447.648-55%12043408.225-22%14383149.093-35%
Net Profit Margin---146.384-65.103-56%-360.181+146%-379.170+159%-246.990+69%
Operating Margin---166.875-105.896-37%-418.518+151%-380.115+128%-239.026+43%
Operating Ratio--167.875107.261+57%421.540-60%221.409-24%188.182-11%
Pb Ratio0.8090%0.8091.387-42%1.311-38%0.549+47%-1.464+281%
Pe Ratio-0.8270%-0.827-13.229+1500%-1.311+59%-2.879+248%-2.356+185%
Price Per Share1.3800%1.3802.527-45%3.083-55%1.585-13%2.030-32%
Price To Free Cash Flow Ratio-1.2670%-1.267-3.417+170%-3.103+145%-2.468+95%-3.266+158%
Price To Total Gains Ratio-7.3120%-7.312-2.057-72%-13.059+79%-6.404-12%1264.165-101%
Quick Ratio--19.99923.363-14%44.427-55%18.337+9%8.946+124%
Return On Assets---0.224-0.151-32%-0.284+27%-0.834+272%-1.159+418%
Return On Equity---0.245-0.164-33%-0.297+21%-0.150-39%-0.073-70%
Total Gains Per Share---0.189-0.095-49%-0.246+30%0.149-226%0.069-373%
Usd Book Value--11548328.00012259420.000-6%16227259.000-29%1385171.632+734%-2437309.744+121%
Usd Book Value Change Per Share---0.189-0.095-49%-0.246+30%0.149-226%0.069-373%
Usd Book Value Per Share--1.7061.811-6%2.397-29%0.660+159%-0.138+108%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.417-0.290-31%-0.615+47%-0.689+65%-0.511+22%
Usd Free Cash Flow---1843450.000-1397497.333-24%-1753884.750-5%-1264537.947-31%-1194138.333-35%
Usd Free Cash Flow Per Share---0.272-0.206-24%-0.259-5%-0.163-40%-0.165-39%
Usd Free Cash Flow To Equity Per Share---0.260-0.091-65%-0.213-18%0.398-165%0.208-225%
Usd Market Cap9342489.6000%9342489.60017105331.200-45%20868447.648-55%12043408.225-22%14383149.093-35%
Usd Price Per Share1.3800%1.3802.527-45%3.083-55%1.585-13%2.030-32%
Usd Profit---2825218.000-1963034.333-31%-4713384.500+67%-3838005.316+36%-3040959.205+8%
Usd Revenue--19300.00038166.667-49%33775.000-43%26610.526-27%46833.103-59%
Usd Total Gains Per Share---0.189-0.095-49%-0.246+30%0.149-226%0.069-373%
 EOD+0 -0MRQTTM+2 -31YOY+15 -195Y+13 -2110Y+14 -20

4.2. Fundamental Score

Let's check the fundamental score of BioRestorative Therapies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.827
Price to Book Ratio (EOD)Between0-10.809
Net Profit Margin (MRQ)Greater than0-146.384
Operating Margin (MRQ)Greater than0-166.875
Quick Ratio (MRQ)Greater than119.999
Current Ratio (MRQ)Greater than110.712
Debt to Asset Ratio (MRQ)Less than10.084
Debt to Equity Ratio (MRQ)Less than10.092
Return on Equity (MRQ)Greater than0.15-0.245
Return on Assets (MRQ)Greater than0.05-0.224
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of BioRestorative Therapies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.692
Ma 20Greater thanMa 501.350
Ma 50Greater thanMa 1001.360
Ma 100Greater thanMa 2001.574
OpenGreater thanClose1.390
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. All numbers in thousands.

Summary
Total Assets12,612
Total Liabilities1,063
Total Stockholder Equity11,548
 As reported
Total Liabilities 1,063
Total Stockholder Equity+ 11,548
Total Assets = 12,612

Assets

Total Assets12,612
Total Current Assets11,391
Long-term Assets1,221
Total Current Assets
Cash And Cash Equivalents 884
Short-term Investments 10,182
Net Receivables 19
Other Current Assets 305
Total Current Assets  (as reported)11,391
Total Current Assets  (calculated)11,391
+/-0
Long-term Assets
Property Plant Equipment 508
Long-term Assets Other 714
Long-term Assets  (as reported)1,221
Long-term Assets  (calculated)1,221
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,063
Long-term Liabilities0
Total Stockholder Equity11,548
Total Current Liabilities
Short-term Debt 162
Accounts payable 189
Other Current Liabilities 712
Total Current Liabilities  (as reported)1,063
Total Current Liabilities  (calculated)1,063
+/- 0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock0
Retained Earnings -167,056
Other Stockholders Equity 178,591
Total Stockholder Equity (as reported)11,548
Total Stockholder Equity (calculated)11,535
+/- 14
Other
Cash and Short Term Investments 11,066
Common Stock Shares Outstanding 4,707
Current Deferred Revenue0
Liabilities and Stockholders Equity 12,612
Net Debt -722
Net Working Capital 10,327
Short Long Term Debt Total 162



Balance Sheet

All numbers in thousands.

 Trend2024-03-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-31
> Total Assets 
7,787
7,926
7,888
8,300
469
1,044
486
403
221
221
1,342
1,397
1,268
1,268
1,250
1,224
1,383
1,383
1,186
1,596
1,692
1,858
2,071
2,151
2,017
2,049
2,196
1,617
1,580
1,481
1,424
1,419
1,759
1,759
1,206
1,251
1,192
1,584
2,432
1,458
1,466
1,378
1,613
1,429
1,466
1,613
2,885
2,175
22,453
20,919
19,441
17,920
16,435
14,081
13,300
13,801
12,612
12,61213,80113,30014,08116,43517,92019,44120,91922,4532,1752,8851,6131,4661,4291,6131,3781,4661,4582,4321,5841,1921,2511,2061,7591,7591,4191,4241,4811,5801,6172,1962,0492,0172,1512,0711,8581,6921,5961,1861,3831,3831,2241,2501,2681,2681,3971,3422212214034861,0444698,3007,8887,9267,787
   > Total Current Assets 
0
0
0
0
18
0
65
64
0
118
47
129
0
31
66
66
0
240
95
422
114
180
246
385
289
384
546
33
62
38
47
36
520
520
76
182
181
647
1,357
201
69
53
344
214
69
344
1,829
1,170
21,468
19,879
18,324
16,888
15,128
12,783
12,044
12,604
11,391
11,39112,60412,04412,78315,12816,88818,32419,87921,4681,1701,8293446921434453692011,357647181182765205203647386233546384289385246180114422952400666631012947118064650180000
       Cash And Cash Equivalents 
0
108
46
31
18
506
7
15
71
72
13
104
0
0
0
1
201
201
59
374
92
146
6
13
167
353
516
6
32
9
2
1
452
452
4
105
118
496
1,284
98
2
5
298
176
2
298
1,759
1,130
21,027
19,323
17,934
6,573
1,677
1,836
1,784
2,437
884
8842,4371,7841,8361,6776,57317,93419,32321,0271,1301,759298217629852981,2844961181054452452129326516353167136146923745920120110001041372711575061831461080
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,914
13,073
10,538
9,832
9,802
10,182
10,1829,8029,83210,53813,0739,914000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
29
93
9
16
5
6
7
20
16
38
38
37
26
29
29
31
38
32
26
19
15
32
19
15
8
5
16
16
45
16
16
25
39
19
19392516164516165815193215192632383129292637383816207651699329510000000000000000000000
       Inventory 
0
0
12
13
0
0
0
0
0
0
0
0
13
12
14
18
18
18
18
17
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000002222171818181814121300000000131200
   > Long-term Assets 
0
0
0
0
450
0
420
339
0
103
1,295
1,268
0
1,237
1,184
1,158
0
1,143
1,091
1,175
1,577
1,678
1,824
1,766
1,728
1,665
1,650
1,584
1,518
1,442
1,377
1,382
0
1,239
1,130
1,069
1,011
937
1,075
1,257
1,397
1,325
1,269
1,215
1,397
1,269
1,056
1,005
986
1,040
1,117
1,032
1,306
1,298
1,256
1,197
1,221
1,2211,1971,2561,2981,3061,0321,1171,0409861,0051,0561,2691,3971,2151,2691,3251,3971,2571,0759371,0111,0691,1301,23901,3821,3771,4421,5181,5841,6501,6651,7281,7661,8241,6781,5771,1751,0911,14301,1581,1841,23701,2681,295103033942004500000
       Property Plant Equipment 
112
135
147
573
447
429
412
331
95
95
79
69
60
59
41
33
36
36
18
74
494
537
702
663
643
599
602
556
509
463
417
370
328
328
257
214
175
141
136
106
0
604
35
29
658
567
429
397
396
469
567
502
503
517
498
461
508
50846149851750350256746939639742956765829356040106136141175214257328328370417463509556602599643663702537494741836363341596069799595331412429447573147135112
       Intangible Assets 
7,665
7,671
7,671
7,671
4
4
3
3
3
3
1,212
1,195
1,177
1,177
1,142
1,125
1,107
1,108
1,073
1,055
1,038
1,095
1,076
1,057
1,039
1,020
1,001
983
964
945
926
908
889
889
852
833
814
795
777
758
739
720
702
683
739
702
627
608
590
571
551
530
803
781
759
736
0
07367597818035305515715906086277027396837027207397587777958148338528898899089269459649831,0011,0201,0391,0571,0761,0951,0381,0551,0731,1081,1071,1251,1421,1771,1771,1951,2123333447,6717,6717,6717,665
       Long-term Assets Other 
0
0
0
0
0
0
4
4
0
4
4
4
0
0
0
0
0
0
0
46
46
46
46
46
46
46
46
46
46
34
34
105
0
22
22
22
22
795
162
394
0
0
532
503
561
445
416
10
0
0
-1,117
-1,032
0
0
-1,256
0
714
7140-1,25600-1,032-1,1170010416445561503532003941627952222222201053434464646464646464646460000000444044000000
> Total Liabilities 
305
277
291
864
1,213
2,488
2,968
3,747
3,907
3,907
5,600
6,475
6,410
6,410
6,986
7,858
8,068
8,068
8,335
8,054
8,580
9,253
4,951
5,927
5,925
5,590
6,201
6,088
6,580
6,202
7,139
8,109
8,596
8,595
11,074
10,189
9,833
9,237
11,375
13,887
14,242
18,914
16,054
16,522
14,242
16,054
6,694
7,054
856
762
856
916
603
594
896
975
1,063
1,0639758965946039168567628567,0546,69416,05414,24216,52216,05418,91414,24213,88711,3759,2379,83310,18911,0748,5958,5968,1097,1396,2026,5806,0886,2015,5905,9255,9274,9519,2538,5808,0548,3358,0688,0687,8586,9866,4106,4106,4755,6003,9073,9073,7472,9682,4881,213864291277305
   > Total Current Liabilities 
305
277
291
443
1,016
2,335
2,814
3,747
3,907
3,907
5,600
6,475
2,816
2,816
3,354
7,858
7,503
7,503
8,258
7,428
8,525
8,922
4,920
5,465
5,612
5,590
5,698
5,549
5,845
6,059
6,994
8,045
8,353
8,353
10,648
8,923
9,255
8,728
11,143
13,715
13,721
18,416
882
1,374
13,721
882
1,326
873
364
494
622
717
440
470
813
933
1,063
1,0639338134704407176224943648731,32688213,7211,37488218,41613,72113,71511,1438,7289,2558,92310,6488,3538,3538,0456,9946,0595,8455,5495,6985,5905,6125,4654,9208,9228,5257,4288,2587,5037,5037,8583,3542,8162,8166,4755,6003,9073,9073,7472,8142,3351,016443291277305
       Short-term Debt 
0
0
0
0
514
0
1,928
2,334
0
3,041
4,321
4,643
0
962
979
4,966
0
4,990
5,906
5,171
5,688
5,463
1,115
1,244
1,010
1,317
1,320
1,298
1,859
1,940
2,433
2,873
3,468
3,468
4,426
3,151
3,626
3,513
5,499
7,526
0
0
0
0
7,231
807
139
159
178
124
129
134
139
145
150
156
162
1621561501451391341291241781591398077,23100007,5265,4993,5133,6263,1514,4263,4683,4682,8732,4331,9401,8591,2981,3201,3171,0101,2441,1155,4635,6885,1715,9064,99004,96697996204,6434,3213,04102,3341,92805140000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,859
1,940
2,553
2,873
3,468
3,694
4,426
3,151
3,626
3,513
5,499
7,526
7,146
8,022
714
1,115
0
15
29
44
59
0
0
0
0
0
0
0
0
000000005944291501,1157148,0227,1467,5265,4993,5133,6263,1514,4263,6943,4682,8732,5531,9401,8590000000000000000000000000000
       Accounts payable 
18
122
108
150
160
72
308
658
426
426
440
700
771
771
1,003
1,156
1,270
1,270
893
774
1,112
1,266
1,747
2,110
2,549
2,194
2,070
1,994
2,284
2,284
2,467
2,718
2,455
2,455
2,277
2,112
1,894
1,568
1,527
1,744
1,954
2,049
75
163
1,954
32
98
125
51
214
378
469
171
93
276
227
189
189227276931714693782145112598321,954163752,0491,9541,7441,5271,5681,8942,1122,2772,4552,4552,7182,4672,2842,2841,9942,0702,1942,5492,1101,7471,2661,1127748931,2701,2701,1561,0037717717004404264266583087216015010812218
       Other Current Liabilities 
8
3
25
113
342
493
578
722
440
396
839
1,133
1,083
1,083
1,372
1,736
1,243
1,243
1,234
1,328
1,561
1,982
1,944
2,009
2,218
2,079
0
2,257
1,702
1,835
2,094
111
2,430
216
1,277
950
1,095
752
946
1,191
916
4,426
807
1,212
916
43
1,089
0
194
156
115
115
130
233
386
549
712
71254938623313011511515619401,089439161,2128074,4269161,1919467521,0959501,2772162,4301112,0941,8351,7022,25702,0792,2182,0091,9441,9821,5611,3281,2341,2431,2431,7361,3721,0831,0831,1338393964407225784933421132538
   > Long-term Liabilities 
0
0
0
0
197
0
154
0
0
0
0
0
0
3,594
3,632
0
0
565
77
627
55
331
32
462
313
0
503
539
735
143
145
64
0
242
426
1,265
579
508
231
171
522
498
15,173
15,147
522
15,173
5,367
6,181
493
268
234
199
162
124
84
42
0
042841241621992342684936,1815,36715,17352215,14715,1734985221712315085791,2654262420641451437355395030313462323315562777565003,6323,59400000015401970000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,270
4,712
5,004
0
0
0
0
0
0
0
0
0
0
00000000005,0044,7124,27000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41
34
0
4
5
24
2
40
11
0
3
52
437
5
25
2
48
5
19
75
55
20
31
14
0
0
14,700
14,700
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000014,70014,7000014312055751954822554375230114022454034410000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71
0
0
0
0
0
0
162
372
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000372162000000710000000000000000000000000000000
> Total Stockholder Equity
7,482
7,649
7,597
7,436
-744
0
-2,483
-3,344
0
-3,686
-4,258
-5,078
0
-5,142
-5,736
-6,634
0
-6,685
-7,149
-6,458
-6,888
-7,395
-2,881
-3,776
-3,908
-3,541
-4,005
-4,471
-5,000
-4,722
-5,715
-6,690
-6,837
-6,837
-9,868
-8,938
-8,641
-7,653
-8,942
-12,429
-12,776
-17,536
-14,441
-15,093
-12,776
-14,441
-3,809
-4,879
21,597
20,157
18,586
17,004
15,832
13,487
12,404
12,826
11,548
11,54812,82612,40413,48715,83217,00418,58620,15721,597-4,879-3,809-14,441-12,776-15,093-14,441-17,536-12,776-12,429-8,942-7,653-8,641-8,938-9,868-6,837-6,837-6,690-5,715-4,722-5,000-4,471-4,005-3,541-3,908-3,776-2,881-7,395-6,888-6,458-7,149-6,6850-6,634-5,736-5,1420-5,078-4,258-3,6860-3,344-2,4830-7447,4367,5977,6497,482
   Common Stock
410
489
499
507
461
529
585
603
636
636
701
718
772
772
17
18
20
20
26
32
35
38
3
3
3
4
4
4
5
5
5
6
6
6
7
9
12
15
20
24
0
159
159
159
8
159
335
0
0
0
0
0
0
0
0
0
0
00000000003351598159159159024201512976665554443333835322620201817772772718701636636603585529461507499489410
   Retained Earnings Total Equity0000000000-109,559-105,496-86,121-84,082-83,245000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0-14000000-1500-879000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,645
68,829
68,425
102,484
105,415
0
0
0
0
0
0
0
0
0
0
0000000000105,415102,48468,42568,82968,645000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000-49-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-61-20-200
   Other Stockholders Equity 
0
0
0
0
2,245
0
2,701
2,835
0
3,202
5,706
6,347
0
8,147
11,125
11,530
0
13,108
15,641
17,426
18,477
19,727
25,697
26,425
29,412
32,266
34,060
35,427
36,955
40,019
41,772
42,849
0
44,562
47,552
51,405
55,269
60,138
63,000
64,567
0
0
0
0
65,786
68,645
105,415
108,864
155,743
159,103
162,207
165,282
168,457
171,797
173,695
177,057
178,591
178,591177,057173,695171,797168,457165,282162,207159,103155,743108,864105,41568,64565,786000064,56763,00060,13855,26951,40547,55244,562042,84941,77240,01936,95535,42734,06032,26629,41226,42525,69719,72718,47717,42615,64113,108011,53011,1258,14706,3475,7063,20202,8352,70102,2450000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue146
Cost of Revenue-166
Gross Profit-20-20
 
Operating Income (+$)
Gross Profit-20
Operating Expense-15,201
Operating Income-15,221-15,221
 
Operating Expense (+$)
Research Development4,035
Selling General Administrative11,332
Selling And Marketing Expenses166
Operating Expense15,20115,532
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-292
Net Interest Income292
 
Pretax Income (+$)
Operating Income-15,221
Net Interest Income292
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-14,415-16,026
EBIT - interestExpense = -15,221
-14,415
-14,415
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-15,221-14,415
Earnings Before Interest and Taxes (EBITDA)-15,055
 
After tax Income (+$)
Income Before Tax-14,415
Tax Provision-0
Net Income From Continuing Ops-15,938-14,415
Net Income-14,415
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses15,367
Total Other Income/Expenses Net805-292
 

Technical Analysis of Biorestorative
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biorestorative. The general trend of Biorestorative is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biorestorative's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioRestorative Therapies Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.45 < 1.5001 < 1.54.

The bearish price targets are: 1.21 > 1.2.

Tweet this
BioRestorative Therapies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioRestorative Therapies Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioRestorative Therapies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioRestorative Therapies Inc. The current macd is -0.00403326.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biorestorative price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biorestorative. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biorestorative price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BioRestorative Therapies Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioRestorative Therapies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioRestorative Therapies Inc. The current adx is 16.22.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biorestorative shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
BioRestorative Therapies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioRestorative Therapies Inc. The current sar is 1.2468.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
BioRestorative Therapies Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioRestorative Therapies Inc. The current rsi is 51.69. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
BioRestorative Therapies Inc Daily Relative Strength Index (RSI) ChartBioRestorative Therapies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioRestorative Therapies Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biorestorative price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
BioRestorative Therapies Inc Daily Stochastic Oscillator ChartBioRestorative Therapies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioRestorative Therapies Inc. The current cci is 60.98.

BioRestorative Therapies Inc Daily Commodity Channel Index (CCI) ChartBioRestorative Therapies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioRestorative Therapies Inc. The current cmo is 9.29369784.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BioRestorative Therapies Inc Daily Chande Momentum Oscillator (CMO) ChartBioRestorative Therapies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioRestorative Therapies Inc. The current willr is -61.36363636.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biorestorative is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioRestorative Therapies Inc Daily Williams %R ChartBioRestorative Therapies Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BioRestorative Therapies Inc.

BioRestorative Therapies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioRestorative Therapies Inc. The current atr is 0.11763706.

BioRestorative Therapies Inc Daily Average True Range (ATR) ChartBioRestorative Therapies Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioRestorative Therapies Inc. The current obv is 39,274,385.

BioRestorative Therapies Inc Daily On-Balance Volume (OBV) ChartBioRestorative Therapies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioRestorative Therapies Inc. The current mfi is 89.64.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
BioRestorative Therapies Inc Daily Money Flow Index (MFI) ChartBioRestorative Therapies Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioRestorative Therapies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

BioRestorative Therapies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioRestorative Therapies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.692
Ma 20Greater thanMa 501.350
Ma 50Greater thanMa 1001.360
Ma 100Greater thanMa 2001.574
OpenGreater thanClose1.390
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biorestorative with someone you think should read this too:
  • Are you bullish or bearish on Biorestorative? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biorestorative? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioRestorative Therapies Inc

I send you an email if I find something interesting about BioRestorative Therapies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioRestorative Therapies Inc.

Receive notifications about BioRestorative Therapies Inc in your mailbox!